Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 410

1.

Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial.

Danhof NA, van Wely M, Repping S, Koks C, Verhoeve HR, de Bruin JP, Verberg MFG, van Hooff MHA, Cohlen BJ, van Heteren CF, Fleischer K, Gianotten J, van Disseldorp J, Visser J, Broekmans FJM, Mol BWJ, van der Veen F, Mochtar MH; SUPER study group .

Hum Reprod. 2018 Oct 1;33(10):1866-1874. doi: 10.1093/humrep/dey268.

PMID:
30137325
2.

The FOAM study: is Hysterosalpingo foam sonography (HyFoSy) a cost-effective alternative for hysterosalpingography (HSG) in assessing tubal patency in subfertile women? Study protocol for a randomized controlled trial.

van Rijswijk J, van Welie N, Dreyer K, van Hooff MHA, de Bruin JP, Verhoeve HR, Mol F, Kleiman-Broeze KA, Traas MAF, Muijsers GJJM, Manger AP, Gianotten J, de Koning CH, Koning AMH, Bayram N, van der Ham DP, Vrouenraets FPJM, Kalafusova M, van de Laar BIG, Kaijser J, van Oostwaard MF, Meijer WJ, Broekmans FJM, Valkenburg O, van der Voet LF, van Disseldorp J, Lambers MJ, Peters HE, Lier MCI, Lambalk CB, van Wely M, Bossuyt PMM, Stoker J, van der Veen F, Mol BWJ, Mijatovic V.

BMC Womens Health. 2018 May 9;18(1):64. doi: 10.1186/s12905-018-0556-6.

3.

The risk of TESE-induced hypogonadism: a systematic review and meta-analysis.

Eliveld J, van Wely M, Meißner A, Repping S, van der Veen F, van Pelt AMM.

Hum Reprod Update. 2018 Jul 1;24(4):442-454. doi: 10.1093/humupd/dmy015.

4.

Association between periconceptional weight loss and maternal and neonatal outcomes in obese infertile women.

van Oers AM, Mutsaerts MAQ, Burggraaff JM, Kuchenbecker WKH, Perquin DAM, Koks CAM, van Golde R, Kaaijk EM, Broekmans FJ, de Bruin JP, van der Veen F, Nap AW, Gondrie ETCM, Mol BWJ, Groen H, Hoek A; LIFEstyle study group.

PLoS One. 2018 Mar 28;13(3):e0192670. doi: 10.1371/journal.pone.0192670. eCollection 2018.

5.

Natural conception rates in couples with unexplained or mild male subfertility scheduled for fertility treatment: a secondary analysis of a randomized controlled trial.

van Eekelen R, Tjon-Kon-Fat RI, Bossuyt PMM, van Geloven N, Eijkemans MJC, Bensdorp AJ, van der Veen F, Mol BW, van Wely M.

Hum Reprod. 2018 May 1;33(5):919-923. doi: 10.1093/humrep/dey051.

PMID:
29538638
6.

Counsellors' practices in donor sperm treatment.

Visser M, Gerrits T, van der Veen F, Mochtar M.

Hum Fertil (Camb). 2018 Mar 14:1-11. doi: 10.1080/14647273.2018.1449970. [Epub ahead of print]

PMID:
29534622
7.

Intrauterine insemination versus intracervical insemination in donor sperm treatment.

Kop PA, Mochtar MH, O'Brien PA, Van der Veen F, van Wely M.

Cochrane Database Syst Rev. 2018 Jan 25;1:CD000317. doi: 10.1002/14651858.CD000317.pub4. Review.

PMID:
29368795
8.

Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis.

Youssef MA, van Wely M, Mochtar M, Fouda UM, Eldaly A, El Abidin EZ, Elhalwagy A, Mageed Abdallah AA, Zaki SS, Abdel Ghafar MS, Mohesen MN, van der Veen F.

Fertil Steril. 2018 Feb;109(2):289-301. doi: 10.1016/j.fertnstert.2017.10.033. Epub 2018 Jan 6.

PMID:
29317127
9.

Reply: GnRH antagonists vs. long GnRH agonists in IVF: significant flaws in a meta-analysis lead to invalid conclusions.

Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, van der Veen F, van Wely M.

Hum Reprod Update. 2017 Dec 29. doi: 10.1093/humupd/dmx038. [Epub ahead of print] No abstract available.

PMID:
29300905
10.

Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial.

Weiss NS, Nahuis MJ, Bordewijk E, Oosterhuis JE, Smeenk JM, Hoek A, Broekmans FJ, Fleischer K, de Bruin JP, Kaaijk EM, Laven JS, Hendriks DJ, Gerards MH, van Rooij IA, Bourdrez P, Gianotten J, Koks C, Lambalk CB, Hompes PG, van der Veen F, Mol BWJ, van Wely M.

Lancet. 2018 Feb 24;391(10122):758-765. doi: 10.1016/S0140-6736(17)33308-1. Epub 2017 Dec 19.

PMID:
29273245
11.

Being a donor-child: wishes for parental support, peer support and counseling.

Schrijvers A, Bos H, van Rooij F, Gerrits T, van der Veen F, Mochtar M, Visser M.

J Psychosom Obstet Gynaecol. 2017 Nov 7:1-9. doi: 10.1080/0167482X.2017.1396313. [Epub ahead of print]

PMID:
29110558
12.

Constructing the crystal ball: how to get reliable prognostic information for the management of subfertile couples.

van Eekelen R, van Geloven N, van Wely M, McLernon DJ, Eijkemans MJ, Repping S, Steyerberg EW, Mol BW, Bhattacharya S, van der Veen F.

Hum Reprod. 2017 Nov 1;32(11):2153-2158. doi: 10.1093/humrep/dex311.

PMID:
29040590
13.

Patient-centered early pregnancy care: a systematic review of quantitative and qualitative studies on the perspectives of women and their partners.

van den Berg MMJ, Dancet EAF, Erlikh T, van der Veen F, Goddijn M, Hajenius PJ.

Hum Reprod Update. 2018 Jan 1;24(1):106-118. doi: 10.1093/humupd/dmx030. Review.

PMID:
29040571
14.

Development of the testis in pre-pubertal boys with cancer after biopsy for fertility preservation.

Uijldert M, Meißner A, de Melker AA, van Pelt AMM, van de Wetering MD, van Rijn RR, van Wely M, van der Veen F, Repping S.

Hum Reprod. 2017 Dec 1;32(12):2366-2372. doi: 10.1093/humrep/dex306.

PMID:
29040511
15.

Selective outcome reporting and sponsorship in randomized controlled trials in IVF and ICSI.

Braakhekke M, Scholten I, Mol F, Limpens J, Mol BW, van der Veen F.

Hum Reprod. 2017 Oct 1;32(10):2117-2122. doi: 10.1093/humrep/dex273. Review.

PMID:
28938740
16.

GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type.

Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, van der Veen F, van Wely M.

Hum Reprod Update. 2017 Sep 1;23(5):560-579. doi: 10.1093/humupd/dmx017. Review.

PMID:
28903472
17.

Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.

Dahhan T, Balkenende EME, Beerendonk CCM, Fleischer K, Stoop D, Bos AME, Lambalk CB, Schats R, van Golde RJT, Schipper I, Louwé LA, Cantineau AEP, Smeenk JMJ, de Bruin JP, Reddy N, Kopeika Y, van der Veen F, van Wely M, Linn SC, Goddijn M.

Contemp Clin Trials. 2017 Oct;61:96-100. doi: 10.1016/j.cct.2017.07.009. Epub 2017 Jul 11.

PMID:
28710053
18.

The SUPER study: protocol for a randomised controlled trial comparing follicle-stimulating hormone and clomiphene citrate for ovarian stimulation in intrauterine insemination.

Danhof NA, van Wely M, Koks CAM, Gianotten J, de Bruin JP, Cohlen BJ, van der Ham DP, Klijn NF, van Hooff MHA, Broekmans FJM, Fleischer K, Janssen CAH, Rijn van Weert JM, van Disseldorp J, Twisk M, Traas M, Verberg MFG, Pelinck MJ, Visser J, Perquin DAM, Boks DES, Verhoeve HR, van Heteren CF, Mol BWJ, Repping S, van der Veen F, Mochtar MH.

BMJ Open. 2017 May 25;7(5):e015680. doi: 10.1136/bmjopen-2016-015680.

19.

Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.

Mochtar MH, Danhof NA, Ayeleke RO, Van der Veen F, van Wely M.

Cochrane Database Syst Rev. 2017 May 24;5:CD005070. doi: 10.1002/14651858.CD005070.pub3. Review.

PMID:
28537052
20.

Cost-effectiveness of single versus double embryo transfer in IVF in relation to female age.

van Loendersloot LL, Moolenaar LM, van Wely M, Repping S, Bossuyt PM, Hompes PGA, van der Veen F, Mol BWJ.

Eur J Obstet Gynecol Reprod Biol. 2017 Jul;214:25-30. doi: 10.1016/j.ejogrb.2017.04.031. Epub 2017 Apr 17.

PMID:
28460276

Supplemental Content

Loading ...
Support Center